Last reviewed · How we verify
Brill-Zinsser disease
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Doxycyclin · Bulovka Hospital
- Vibramycin · Generic (originally Pfizer)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Brill-Zinsser disease patent landscape — cliff calendar, originator estates, attackable patents
- Brill-Zinsser disease treatment landscape brief
- Brill-Zinsser disease treatment updates RSS
Frequently asked questions about Brill-Zinsser disease
What drugs treat Brill-Zinsser disease?
Tracked treatments include Ramycin, Doxycyclin, Vibramycin.
What is the treatment for Brill-Zinsser disease?
Standard treatment for Brill-Zinsser disease includes Ramycin, Doxycyclin, Vibramycin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Brill-Zinsser disease patent cliff · Brill-Zinsser disease CI report
- Treatment: Ramycin
- Treatment: Doxycyclin · Bulovka Hospital
- Treatment: Vibramycin · Generic (originally Pfizer)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing